Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2021
/
Article
/
Tab 3
/
Research Article
[Retracted] Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer
Table 3
Survival comparison (
n
(%)).
Group
First year
Third year
Fifth year
Control group (
n
= 58)
53.45 (31/58)
32.76 (19/58)
18.97 (11/58)
Observation group (
n
= 58)
72.41 (42/58)
51.72 (30/58)
37.93 (22/58)
χ
2
4.472
4.275
5.125
0.034
0.039
0.024